Tus%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd

# Tus%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd ## Overview Tus%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd is a combination medication containing tussigon and guaifenesin. Tussigon is a non-narcotic cough suppressant, and guaifenesin is an expectorant. ## Primary Indications * Relief of cough associated with the common cold. * Aids in loosening phlegm (mucus) and thinning bronchial secretions to make coughs more productive. ## Adult Dosing * **Tussigon/Guaifenesin:** 10 mL orally every 4 hours as needed. * Maximum dose not explicitly established, but typical practice limits to avoid excessive guaifenesin intake. ## Pediatric Dosing * **Children 6 to under 12 years of age:** 5 mL orally every 4 hours as needed. * **Children under 6 years of age:** Consult a pediatrician. Dosing is not well-established for this age group. ## Dose Adjustments * No specific dose adjustments are recommended for renal or hepatic impairment. However, caution should be exercised, and lower doses may be considered in patients with severe impairment. ## Contraindications * Hypersensitivity to any component of the formulation. * Use with MAO inhibitors or within 14 days of stopping MAO inhibitors. ## Adverse Effects * **Common:** Nausea, vomiting, stomach upset, dizziness, drowsiness. * **Less Common:** Rash, headache. ## Key Drug Interactions * **Monoamine Oxidase Inhibitors (MAOIs):** Concomitant use may lead to severe hypertension. * **Central Nervous System (CNS) Depressants:** Increased risk of sedation and respiratory depression when used with other CNS depressants (e.g., alcohol, benzodiazepines, opioids). ## Monitoring * Assess cough frequency and sputum production. * Monitor for signs of adverse effects, particularly drowsiness and gastrointestinal upset. ## Clinical Pearls * This combination is generally considered safe and effective for symptomatic relief of cough and congestion. * Ensure adequate hydration when using guaifenesin to promote thinning of mucus. * Advise patients to avoid driving or operating heavy machinery if drowsiness occurs. * If cough persists for more than 7 days, is accompanied by fever, rash, or persistent headache, discontinue use and consult a healthcare provider. *** **Disclaimer:** This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and local protocols for definitive patient management.